KINFO: Kurssi-ilmoitus (biotekniikka)

[Tuomo Liljenbäck]

Terve.

Biotekniikan syventävästä kurssista Biotechnology in Health and Disease tuli tarkempaa tietoa, olkaapa hyvä.
Aktiivinen läsnäolo = 1 ov (2 op), tentti tuo vielä 1 ov (2 op) lisää. Ilmoittautumiset korkeakoulusihteeri Marja-Liisa Knuutille.

-Tuomo


The Department of Biotechnology Series
"Biotechnology in Health and Disease"
TARGETS, METHODOLOGIES AND CLINICAL CORRELATION IN CANCER DIAGNOSTICS AND THERAPEUTICS
[Advanced study course of in Molecular Biotechnology and In vitro Diagnostics 
- 2 ECTS for active attending + 2 ECTS for the examination]
December 11-13 2006

Monday 11th  – PharmaCity Aud I
(Address: Itäinen pitkäkatu 4)

12.30 		Introduction   -  prof. Kim Pettersson

12.40		Prostate biology and prostate cancer
		Prof. Chung Lee, PhD			
		Northwestern University, Feinberg School of Medicine, Chicago.	

13.30		Estrogens, phytoestrogens and prostate cancer
Prof. Sari Mäkelä, MD, PhD, University of Turku.

14.10 		Testing for circulating forms of prostatic kallikreins
		Ville Väisänen MSc, Mari Peltola MSc, University of Turku

14.40	           Coffee break

15.00	Perspectives on kallikrein testing in prostate cancer diagnosis and prognosis
	Prof. Hans Lilja, MD, PhD, Memorial Sloan Kettering Cancer Center, New York

16.00		The practical use of kallikrein testing in prostate cancer diagnostics.
Prof. Ulf-Håkan Stenman, MD, PhD, University of Helsinki.

16.30	Functional genomics and transcriptomics of prostate cancer: promises and limitations.
	Prof Olli Kallioniemi, PhD, VTT Technical Research Centre of Finland, and University of Turku.

Session to end at ≈ 17.30


Tuesday 12th – Auditorium Salus
(Address: Lemminkäisenkatu 1 -  3rd floor)

8.30	Micro-technology platform and mass spectrometry for biomarker detection and discovery
Simon Ekström, PhD, Lund Institute of Technology, Lund University, Sweden.
								
9.15 		Novel fluorescent reporter technologies of high specific activity.
		Tero Soukka, PhD, University of Turku.

9.45 		Innovative approaches to high through-put screening.
		Leena Kokko, MSc, University of Turku.

10.15 		Break
		
10.30		Array-based high throughput tools for cancer research	
Petri Saviranta, PhD, VTT Technical Research Centre of Finland, Turku.
		
11.00		Solid phases of high functional densities
		Lasse Välimaa, Johanna Ylikotila, University of Turku.

11.30     	Lunch break

12.30 	Modulation of kallikrein activity as a therapeutical approach.
Prof. Ulf-Håkan Stenman, MD PhD, University of Helsinki.

13.15 	Proteomics in prostate cancer: the quest for novel serum biomarkers"
Guido Jenster, PhD, Department of Urology, Erasmus MC, Rotterdam.

14.00		Break

14.15	What are we about to learn from the prostate cancer screening studies?
Prof.dr. Fritz H Schröder, Department of Urology, Erasmus MC, University Medical Center, Rotterdam.

15.15 		Antibody libraries to provide reagents for novel targets.	
Eeva Brockmann, MSc, University of Turku

15.45		Concept for quantitation of gene expression by real-time RT-PCR.
	Maria Rissanen MSc, R-M Väänänen MSc, Univeristy of Turku.							
16.15		Fully automated concept for quantification of nucleic acids.
		Jussi Nurmi, PhD, Abacus Diagnostica Oy, Turku.

Session to end at  ≈ 17.15


Wednesday 13th  - PharmaCity Aud I
(Address: Itäinen pitkäkatu 4)

8.30 		TGFß and cancer therapeutics
Prof. Chung Lee, PhD, Northwestern University, Feinberg School of Medicine, Chicago.	

9.30		Chemoprevention in prostate cancer management.
Prof.dr. Fritz H Schröder, Department of Urology, Erasmus MC, University Medical Center, Rotterdam.

10.30		Integrins and cancer
Johanna Ivaska, PhD, VTT Technical Research Centre for Finland, Medical Biotechnology, Turku.

Session to end at  ≈ 11.15


Advance registration by 5th December
Marja-Liisa Knuuti, 02-3338053, email marja-liisa.knuuti at utu.fi